| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 45 |
| Sex | Both Genders |
3g of EPA for 24 weeks in persons suffering from lupus was able to confer some benefit to symptoms as assessed by the SLAM-R rating scale.
| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 45 |
| Sex | Both Genders |
3g of EPA for 24 weeks in persons suffering from lupus was able to confer some benefit to symptoms as assessed by the SLAM-R rating scale.